Amanda Hill
Nurse Practitioner · Cleveland, MSNPI 1669990040
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 221 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 39.0% of the total. 2025 is the largest year on record at $1,122, 2.5 times the $441 reported in 2021. Among nurse practitioner clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 221 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Abbott$1K
- Bard Peripheral Vascular, Inc.$230
- Philips North America LLC$217
- Takeda Pharmaceuticals U.S.A., Inc.$142
- Johnson & Johnson$133
- plus $593 from 13 others
What the payments were for
- Food & beverage$4,118100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 83 | $1,607 |
| Abbott | 73 | $1,197 |
| Bard Peripheral Vascular, Inc. | 10 | $230 |
| Philips North America LLC | 10 | $217 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $142 |
| Johnson & Johnson | 6 | $133 |
| Lilly USA, LLC | 6 | $106 |
| Intercept Pharmaceuticals, Inc. | 6 | $92 |
| Ironwood Pharmaceuticals, Inc | 4 | $70 |
| Pharmacosmos Therapeutics Inc. | 3 | $62 |
| QOL Medical, LLC | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 2 | $39 |
| Medtronic | 2 | $37 |
| Evoke Pharma, Inc. | 2 | $32 |
| Gilead | 1 | $25 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Dexcom, Inc. | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Pfizer | 1 | $14 |
How this compares
$4,118 in reported general payments places this provider in the 90th percentile of 1,090 nurse practitioner providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cilostazol | 131 | $2,269 |
| ClopidogrelClopidogrel Bisulfate | 59 | $779 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $21 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Cleveland
- Christina TreppendahlRidgeland$125K
- Jo Anna WarrenJackson$73K
- Marisa StringerBiloxi$68K
- Sara KlausFlowood$48K
- Micaela PerkinsOxford$32K
- Michelle TharpJackson$28K
- Kaylon LewisHattiesburg$25K
- Jennifer HollyJackson$16K
- Mariah CoxGulfport$14K
- Brittany HicksGulfport$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.